In this episode of the Personalized Medicine Podcast we talk about precision oncology with a scientist and serial entrepreneur, Dr. Gang Song. Gang completed his PhD degree in Biochemistry and Molecular Biology at the Shanghai Medical College of Fudan University and then moved to Harvard where he did a PostDoc at the lab of Tim Springer where he was studying structure and function of cell adhesion molecules. Gang has extensive experience in the life science industry working at various positions at IQuum, which was acquired by Roche, Genzyme Genetics and LabCorp. In 2014, Gang founded Pillar Biosciences, a precision medicine company developing genomics tests for various types of cancer. Gang also co-founded another venture, AffyImmune Therapeutics which is focusing on developing novel cell therapies for cancer based on CAR-T technologies. Together with Gang we discussed: ◦ His career from PhD in China to founding multiple successful biotech companies in the US ◦ Mentorship lessons from Professor Tim Springer ◦ Founding story of Pillar Biosciences ◦ Novel NGS approaches for early cancer detection ◦ Differences in business models pursued by diagnostics companies in oncology ◦ Next generation of CAR-T cell therapeutics ◦ Future of precision oncology ◦ Gang's advice to aspiring biotech entrepreneurs Get in touch with Gang: ◦ LinkedIn: Gang Song, Pillar Biosciences, Affyimmune ◦ Twitter: @pillar_bio, @affyimmune ◦ Web: https://affyimmune.com/, https://pillar-biosciences.com/ Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com